K K Fu

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
    K K Fu
    Department of Radiation Oncology, University of California San Francisco, 94143 0226, USA
    Int J Radiat Oncol Biol Phys 48:7-16. 2000
  2. ncbi Lymph node metastasis in maxillary sinus carcinoma
    Q T Le
    Department of Radiation Oncology, Stanford University, CA 94305 5302, USA
    Int J Radiat Oncol Biol Phys 46:541-9. 2000
  3. ncbi Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials
    J D Cox
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Int J Radiat Oncol Biol Phys 43:505-9. 1999
  4. ncbi Treatment results of carcinoma in situ of the glottis: an analysis of 82 cases
    Q T Le
    Department of Radiation Oncology, Stanford University Medical Center, 300 Pasteur Dr, Stanford, CA 94305 5302, USA
    Arch Otolaryngol Head Neck Surg 126:1305-12. 2000
  5. ncbi Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma
    P Xia
    Department of Radiation Oncology, University of California at San Francisco, San Francisco, CA 94143, USA
    Int J Radiat Oncol Biol Phys 48:329-37. 2000
  6. ncbi Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience
    P F Nguyen-Tan
    Department of Radiation Oncology, University of California, San Francisco, CA, USA
    Int J Radiat Oncol Biol Phys 50:1172-80. 2001

Detail Information

Publications6

  1. ncbi A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
    K K Fu
    Department of Radiation Oncology, University of California San Francisco, 94143 0226, USA
    Int J Radiat Oncol Biol Phys 48:7-16. 2000
    ..The objective of this randomized trial was to test the efficacy of hyperfractionation and two types of accelerated fractionation individually against standard fractionation...
  2. ncbi Lymph node metastasis in maxillary sinus carcinoma
    Q T Le
    Department of Radiation Oncology, Stanford University, CA 94305 5302, USA
    Int J Radiat Oncol Biol Phys 46:541-9. 2000
    ..To evaluate the incidence and prognostic significance of lymph node metastasis in maxillary sinus carcinoma...
  3. ncbi Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials
    J D Cox
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Int J Radiat Oncol Biol Phys 43:505-9. 1999
    ..To evaluate the influence of cell type within non-small cell carcinoma of lung (NSCCL) on failure patterns when chemotherapy (CT) is combined with radiation therapy (RT)...
  4. ncbi Treatment results of carcinoma in situ of the glottis: an analysis of 82 cases
    Q T Le
    Department of Radiation Oncology, Stanford University Medical Center, 300 Pasteur Dr, Stanford, CA 94305 5302, USA
    Arch Otolaryngol Head Neck Surg 126:1305-12. 2000
    ..To evaluate the results of different treatment modalities for carcinoma in situ of the glottis, and to identify important prognostic factors for outcome...
  5. ncbi Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma
    P Xia
    Department of Radiation Oncology, University of California at San Francisco, San Francisco, CA 94143, USA
    Int J Radiat Oncol Biol Phys 48:329-37. 2000
    ..To compare intensity-modulated radiotherapy (IMRT) treatment plans with conventional treatment plans for a case of locally advanced nasopharyngeal carcinoma...
  6. ncbi Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience
    P F Nguyen-Tan
    Department of Radiation Oncology, University of California, San Francisco, CA, USA
    Int J Radiat Oncol Biol Phys 50:1172-80. 2001
    ..To review the UCSF-SUH experience in the treatment of advanced T3--4 laryngeal carcinoma and to evaluate the different factors affecting locoregional control and survival...